# NNN REIT, Inc.: financial statements, quarterly

NNN · NYSE · CIK 751364 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nnn.md) · [Financials](/companies/nnn/financials.md) · [Filings](/companies/nnn/filings.md) · [Insiders](/companies/nnn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nnn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [203](/filings/0000950170-24-088971.md) | [205](/filings/0000950170-24-119258.md) | [216 d](/filings/0001193125-26-045617.md) | [215](/filings/0000950170-25-061454.md) | [217](/filings/0000950170-25-102429.md) | [219](/filings/0001193125-25-263643.md) | [218 d](/filings/0001193125-26-045617.md) | [231](/filings/0000950170-25-061454.md) | [227](/filings/0001193125-26-333967.md) | [230](/filings/0001193125-25-263643.md) | [238 d](/filings/0001193125-26-045617.md) | [244](/filings/0001193125-26-333967.md) |
| Operating income | $m | [139](/filings/0000950170-24-088971.md) | [148](/filings/0000950170-24-119258.md) | [140 d](/filings/0001193125-26-045617.md) | [138](/filings/0000950170-25-061454.md) | [152](/filings/0000950170-25-102429.md) | [144](/filings/0001193125-25-263643.md) | [144 d](/filings/0001193125-26-045617.md) | [144](/filings/0000950170-25-061454.md) | [150](/filings/0001193125-26-333967.md) | [147](/filings/0001193125-25-263643.md) | [149 d](/filings/0001193125-26-045617.md) | [151](/filings/0001193125-26-333967.md) |
| Interest expense | $m | [40.1](/filings/0000950170-24-088971.md) | [41.5](/filings/0000950170-24-119258.md) | [43.4 d](/filings/0001193125-26-045617.md) | [44.1](/filings/0000950170-25-061454.md) | [46.6](/filings/0000950170-25-102429.md) | [46.5](/filings/0001193125-25-263643.md) | [46.9 d](/filings/0001193125-26-045617.md) | [47.7](/filings/0000950170-25-061454.md) | [49.3](/filings/0001193125-26-333967.md) | [53.4](/filings/0001193125-25-263643.md) | [53.6 d](/filings/0001193125-26-045617.md) | [53.5](/filings/0001193125-26-333967.md) |
| Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [98.7](/filings/0000950170-24-088971.md) | [107](/filings/0000950170-24-119258.md) | [96.7 d](/filings/0001193125-26-045617.md) | [94.4](/filings/0000950170-25-061454.md) | [107](/filings/0000950170-25-102429.md) | [97.9](/filings/0001193125-25-263643.md) | [97.9 d](/filings/0001193125-26-045617.md) | [96.5](/filings/0000950170-25-061454.md) | [101](/filings/0001193125-26-333967.md) | [96.8](/filings/0001193125-25-263643.md) | [96.0 d](/filings/0001193125-26-045617.md) | [97.9](/filings/0001193125-26-333967.md) |
| Diluted EPS | $ per share | [0.54](/filings/0000950170-24-088971.md) | [0.59](/filings/0000950170-24-119258.md) | not reported | [0.52](/filings/0000950170-25-061454.md) | [0.58](/filings/0000950170-25-102429.md) | [0.53](/filings/0001193125-25-263643.md) | not reported | [0.51](/filings/0000950170-25-061454.md) | [0.54](/filings/0001193125-26-333967.md) | [0.51](/filings/0001193125-25-263643.md) | not reported | [0.52](/filings/0001193125-26-333967.md) |
| Basic EPS | $ per share | [0.54](/filings/0000950170-24-088971.md) | [0.59](/filings/0000950170-24-119258.md) | not reported | [0.52](/filings/0000950170-25-061454.md) | [0.58](/filings/0000950170-25-102429.md) | [0.53](/filings/0001193125-25-263643.md) | not reported | [0.52](/filings/0000950170-25-061454.md) | [0.54](/filings/0001193125-26-333967.md) | [0.51](/filings/0001193125-25-263643.md) | not reported | [0.52](/filings/0001193125-26-333967.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: not reported
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | period not labelled (2026-01-15) | period not labelled (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1.2](/filings/0000950170-25-017472.md) | [1.1](/filings/0000950170-24-050913.md) | [2.1](/filings/0000950170-24-088971.md) | [174](/filings/0000950170-24-119258.md) | [8.7](/filings/0001193125-26-045617.md) | [5.1](/filings/0000950170-25-061454.md) | [6.0](/filings/0000950170-25-102429.md) | [158](/filings/0001193125-25-263643.md) | [5.0](/filings/0001193125-26-333967.md) | not reported | not reported | [4.2](/filings/0001193125-26-333967.md) |
| Total assets | $m | [8,662](/filings/0000950170-25-017472.md) | [8,706](/filings/0000950170-24-050913.md) | [8,727](/filings/0000950170-24-088971.md) | [8,924](/filings/0000950170-24-119258.md) | [8,873](/filings/0001193125-26-045617.md) | [9,022](/filings/0000950170-25-061454.md) | [9,149](/filings/0000950170-25-102429.md) | [9,480](/filings/0001193125-25-263643.md) | [9,379](/filings/0001193125-26-333967.md) | not reported | not reported | [9,607](/filings/0001193125-26-333967.md) |
| Total liabilities | $m | [4,505](/filings/0000950170-25-017472.md) | [4,531](/filings/0000950170-24-050913.md) | [4,532](/filings/0000950170-24-088971.md) | [4,555](/filings/0000950170-24-119258.md) | [4,510](/filings/0001193125-26-045617.md) | [4,665](/filings/0000950170-25-061454.md) | [4,786](/filings/0000950170-25-102429.md) | [5,060](/filings/0001193125-25-263643.md) | [4,971](/filings/0001193125-26-333967.md) | not reported | not reported | [5,146](/filings/0001193125-26-333967.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [200](/filings/0001193125-26-045617.md) | not reported | not reported |
| Shareholders' equity | $m | [4,157](/filings/0000950170-25-017472.md) | [4,175](/filings/0000950170-24-050913.md) | [4,195](/filings/0000950170-24-088971.md) | [4,369](/filings/0000950170-24-119258.md) | [4,362](/filings/0001193125-26-045617.md) | [4,356](/filings/0000950170-25-061454.md) | [4,362](/filings/0000950170-25-102429.md) | [4,420](/filings/0001193125-25-263643.md) | [4,408](/filings/0001193125-26-333967.md) | not reported | [4,395](/filings/0001193125-26-333967.md) | [4,461](/filings/0001193125-26-333967.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [181](/filings/0000950170-24-050913.md) | [118 d](/filings/0000950170-24-088971.md) | [192 d](/filings/0000950170-24-119258.md) | [122 d](/filings/0001193125-26-045617.md) | [191](/filings/0000950170-25-061454.md) | [120 d](/filings/0000950170-25-102429.md) | [207 d](/filings/0001193125-25-263643.md) | [118 d](/filings/0001193125-26-045617.md) | [203](/filings/0000950170-25-061454.md) | [119 d](/filings/0001193125-26-333967.md) | [218 d](/filings/0001193125-25-263643.md) | [126 d](/filings/0001193125-26-045617.md) |
| Dividends paid | $m | [99.4](/filings/0000950170-24-050913.md) | [99.7 d](/filings/0000950170-24-088971.md) | [103 d](/filings/0000950170-24-119258.md) | [103 d](/filings/0001193125-26-045617.md) | [103](/filings/0000950170-25-061454.md) | [103 d](/filings/0000950170-25-102429.md) | [106 d](/filings/0001193125-25-263643.md) | [108 d](/filings/0001193125-26-045617.md) | [108](/filings/0000950170-25-061454.md) | [109 d](/filings/0001193125-26-333967.md) | [113 d](/filings/0001193125-25-263643.md) | [113 d](/filings/0001193125-26-045617.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [175](/filings/0000950170-23-036795.md) | [177](/filings/0000950170-23-057144.md) | [181](/filings/0000950170-24-050913.md) | [182](/filings/0000950170-24-088971.md) | [182](/filings/0000950170-24-119258.md) | [182](/filings/0000950170-25-061454.md) | [183](/filings/0000950170-25-102429.md) | [185](/filings/0001193125-25-263643.md) | [187](/filings/0000950170-25-061454.md) | [187](/filings/0001193125-26-333967.md) | [188](/filings/0001193125-25-263643.md) | [190](/filings/0001193125-26-333967.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 191,931,400 at 2026-07-30, from the cover of the [10-Q filed 2026-08-05](/filings/0001193125-26-333967.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.